Andrea Wilson
I am interested in understanding how Trop2 post-translational modifications lead to oncogenesis, along with how this affects therapeutic targeting in triple negative breast cancer. I am also researching the immunosuppressive role of progesterone receptor (PR) in hormone receptor positive breast cancer and understanding best targeting therapeutic strategies of PR to decrease and eliminate tumor burden.
